Genmab AS (GMAB)
21.21
-0.46
(-2.12%)
USD |
NASDAQ |
Nov 14, 16:00
21.21
0.00 (0.00%)
After-Hours: 18:31
Genmab Gross Profit Margin (Quarterly): 95.07% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 95.07% |
June 30, 2024 | 96.48% |
March 31, 2024 | 95.53% |
December 31, 2023 | 97.35% |
September 30, 2023 | 98.32% |
June 30, 2023 | 99.50% |
March 31, 2023 | |
December 31, 2022 | |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 |
Date | Value |
---|---|
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
95.07%
Minimum
Sep 2024
99.50%
Maximum
Jun 2023
97.04%
Average
96.92%
Median
Gross Profit Margin (Quarterly) Benchmarks
Novo Nordisk AS | 84.14% |
Ascendis Pharma AS | 68.15% |
Galecto Inc | -- |
Evaxion Biotech AS | -- |
IO Biotech Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | 14.86% |
Return on Assets | 12.66% |
Return on Invested Capital | 14.86% |
Profit Margin (Quarterly) | 22.85% |
Operating Margin (Quarterly) | 38.25% |
Return on Net Operating Assets | 35.82% |